Your browser doesn't support javascript.
loading
Diagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation.
Konno, T; Yoshida, K; Mizuta, I; Mizuno, T; Kawarai, T; Tada, M; Nozaki, H; Ikeda, S-I; Onodera, O; Wszolek, Z K; Ikeuchi, T.
Afiliação
  • Konno T; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Yoshida K; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Mizuta I; Department of Brain Disease Research, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
  • Mizuno T; Department of Neurology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.
  • Kawarai T; Department of Neurology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.
  • Tada M; Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
  • Nozaki H; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Ikeda SI; Department of Medical Technology, School of Health Sciences Faculty of Medicine, Niigata University, Niigata, Japan.
  • Onodera O; Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
  • Wszolek ZK; Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
  • Ikeuchi T; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Eur J Neurol ; 25(1): 142-147, 2018 01.
Article em En | MEDLINE | ID: mdl-28921817
ABSTRACT
BACKGROUND AND

PURPOSE:

To establish and validate diagnostic criteria for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) due to colony-stimulating factor 1 receptor (CSF1R) mutation.

METHODS:

We developed diagnostic criteria for ALSP based on a recent analysis of the clinical characteristics of ALSP. These criteria provide 'probable' and 'possible' designations for patients who do not have a genetic diagnosis. To verify its sensitivity and specificity, we retrospectively applied our criteria to 83 ALSP cases who had CSF1R mutations (24 of these were analyzed at our institutions and the others were identified from the literature), 53 cases who had CSF1R mutation-negative leukoencephalopathies and 32 cases who had cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) with NOTCH3 mutations.

RESULTS:

Among the CSF1R mutation-positive cases, 50 cases (60%) were diagnosed as 'probable' and 32 (39%) were diagnosed as 'possible,' leading to a sensitivity of 99% if calculated as a ratio of the combined number of cases who fulfilled 'probable' or 'possible' to the total number of cases. With regard to specificity, 22 cases (42%) with mutation-negative leukoencephalopathies and 28 (88%) with CADASIL were correctly excluded using these criteria.

CONCLUSIONS:

These diagnostic criteria are very sensitive for diagnosing ALSP with sufficient specificity for differentiation from CADASIL and moderate specificity for other leukoencephalopathies. Our results suggest that these criteria are useful for the clinical diagnosis of ALSP.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Axônios / Neuroglia / Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos / Esferoides Celulares / Leucoencefalopatias Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Axônios / Neuroglia / Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos / Esferoides Celulares / Leucoencefalopatias Idioma: En Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos